ClinicalMetric / Countries / Switzerland / advanced solid tumors
← 🇨🇭 Switzerland Trials
🇨🇭 Switzerland Country × Condition

advanced solid tumors Clinical Trials in Switzerland

Active clinical trials for advanced solid tumors with research sites in Switzerland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇭 Switzerland

Active Trials in Switzerland (2)

NCT07793942 Phase 2
Recruiting

A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)

Enrollment
480 pts
Country
🇨🇭 Switzerland
Merck Sharp & Dohme LLC
View Trial →
NCT07785609 Phase 2
Recruiting

A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)

Enrollment
200 pts
Country
🇨🇭 Switzerland
Merck Sharp & Dohme LLC
View Trial →

Frequently Asked Questions

How many advanced solid tumors clinical trials are active in Switzerland?
There are currently 2 active clinical trials for advanced solid tumors with sites in Switzerland, of which 2 are actively recruiting patients.
How can I join a advanced solid tumors clinical trial in Switzerland?
To join a advanced solid tumors clinical trial in Switzerland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Switzerland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are advanced solid tumors trials in Switzerland?
Active advanced solid tumors trials in Switzerland span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Switzerland Trials → Global advanced solid tumors Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology